Johnson & Johnson to Invest $1bn in Jacksonville Lens Plant, Facility by 2028
JNJ•Johnson & Johnson has invested $1bn to expand its Jacksonville contact lens manufacturing and build a distribution facility by 2028, part of a $55bn US manufacturing expansion through 2029. The company supplies over 1.7bn ACUVUE lenses annually and posted Q1 US contact lens revenue of $468m, up 3.7% YoY.
1. Investment Details
Johnson & Johnson has allocated $1bn to strengthen contact lens manufacturing in Jacksonville by enhancing advanced manufacturing and packaging capabilities.
2. Expansion Context
This investment is part of a broader $55bn commitment to expand US manufacturing to 2029, including forthcoming cell therapy and biologics facilities in Pennsylvania and North Carolina.
3. Production and Revenue Impact
Johnson & Johnson produces over 1.7bn ACUVUE lenses annually and reported Q1 US contact lens revenue of $468m, a 3.7% year-on-year increase.
4. Scheduled Completion
The upgraded Jacksonville site will include a new distribution facility slated for operation in 2028, boosting supply chain resilience.
